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ABSTRACT 
In many nephrotic syndrome children, it has been observed that onset of rhinitis and/or wheezing attacks precipitate the relapse 
of nephrotic syndrome. This association is known since long time. We decided to observe the response of inhalation steroids in 
prevention of relapses of nephrotic syndrome in children who presented with frequently relapsing nephrotic syndrome and 
coexistent atopic disorders.  
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ssociation of idiopathic nephrotic syndrome and 
atopic disorders has been observed by fanconi et 
al for the first time in 1951 and then by many 
observers [1-3]. Whether it is a type of allergic disorder, 
the evidence is scarce [4]. We share our experience of 
seven patients with asthma and rhinitis who also had 
idiopathic nephrotic syndrome with frequent steroid 
responsive relapses. These were given inhalational steroids 
for allergic rhinitis or asthma; however, it also prevented 
the further relapses of nephritic syndrome. 
CASE DETAILS 
It was a prospective observational study conducted in 
pediatric nephrology clinic of a tertiary care hospital from 
July 2010 to June 2012. We found that, out of 55 patients 
of idiopathic nephrotic syndrome, seven patients (12.7%) 
had atopic disorders which were diagnosed clinically. We 
could not perform serum Ig E levels or allergy test in these 
children because of economic constraints. Renal biopsies 
were not done as there was no indication. The clinical 
details and their response to steroids are depicted in table -
1. Each relapse of nephrotic syndrome was precipitated by 
an episode of exacerbation of wheezing or rhinitis. The 
frequency of relapses varied from 3-8/ year.  
These were treated with oral prednisolone 2mg.kg/day 
till remission and 1.5mg/kg/alternate day for 4 weeks 
along with the treatment of underlying infection. When 
they went into remission oral steroids were stopped and 
because of history of recurrent wheezing /rhinitis episodes, 
followed by relapses of NS, we started them on inhalation 
steroids. During 12 months followup after starting 
inhalation steroids, these patients neither had any 
exacerbation of asthma /rhinitis nor did they had any 
relapse of nephrotic syndrome.  
DISCUSSION 
Association of atopy with idiopathic nephrotic syndrome 
was first time observed by Fanconi et al in 1951 [1]. 
Children with idiopathic nephrotic syndrome have been 
reported to have relapses on exposure to various allergens 
[5-8]. The prevalence of atopy in patients with idiopathic 
nephrotic syndrome varies from 10-50%, and tendency for 
increasing prevalence has been observed [9-11]. In our 
A 
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study, the prevalence was 12.5%. This association has 
been suggested by following: presentation with and 
precipitation by allergic disorders (both aero and food 
allergens) [2,5-8], seasonal variations [12,13], increase 
serum IgE levels in patients with steroid responsive 
nephrotic syndrome and more so in frequent relapsers  
[2,4,9,13], increased levels of Interlukin-13 [14-16], and 
association with HLA B12 antigen [17]. 
 
Table-1 Clinical details of patients and their response to inhalation steroids 
S 
no 
Age 
(years) 
/Sex 
Associated  
atopic 
disorder  
Relapses  
in previous  
year  
Inhalation Steroids  
(Doses in µg) 
Relapses 
after  
treatment 
1  3 F Asthma  3  MDI Budesonide (200), 1 puff BD None 
2  5 M Asthma  4  MDI Fluticasone + Salmeterol (125+25), 1 puff BD None 
3  6 M Asthma  4  MDI Budesonide (200), 1 puff BD None 
4 8 M Asthma  6  MDI Budesonide (200), 1 puff BD None 
5 11 M Asthma  4 MDI Budesonide (200), 1 puff BD None 
6  5 M Allergic rhinitis  4  Fluticasone nasal spray (50) OD None 
7  6 F Allergic rhinitis  3  Fluticasone nasal  spray(50) OD None 
 
Association of idiopathic nephrotic syndrome (minimal 
change disease) with atopy is probably the result of 
underlying immune system which predisposes them to 
both diseases. Interlukin-13 has been found to be increased 
in patients with minimal change disease. Interlukin-13 
cause switchover from IgM to IgE in B cells and induces 
increased CD80 expressions by podocytes which leads to 
proteinuria [4]. 
Patients with first episode of nephritic syndrome is 
treated with oral prednisolone 2mg/kg/day daily in divided 
doses for 6 weeks and then 1.5 mg/kg/alternate day single 
dose for 6 weeks. The treatment for relapse of steroid 
sensitive FRNS is treatment of underlying infection and if 
required oral prednisolone 2mg.kg/day till remission and 
1.5mg/kg/alternate day for 4 weeks. A frequently relapsing 
and steroid dependent NS is treated with prolong course 
(9–18 months) of oral prednisolone 0.5 to 0.7mg/kg, 
alternate day. Immunotherapy may cause remission in 
these patients but results are not consistent [5,18]. Further 
molecular studies could result in novel therapies, such as 
the use of CTLA-4 IgG that specifically target CD80.  
In this study group, all the patients had frequent 
wheezing or rhinitis episodes which every time 
precipitated the relapse of nephrotic syndrome. These 
patients were referred to asthma clinic for frequent 
wheezing / rhinitis episodes and inhalational steroids were 
prescribed to them for rhinitis/ asthma. However, on 
follow up, we found there were no relapses of nephrotic 
syndrome also along with decreased incidences of 
wheezing attacks and all these patients remained in 
remission during one year followup with inhalation 
steroids only. However, this was a simple observation only 
and we could not find any previous studies.  
We could not confirm the association of inhalational 
steroids and prevention of relapses of nephrotic syndrome 
by any immunological study due to limitations of 
resources. However, further large scale studies can be 
conducted to explore this potential modality of treatment 
to prevent relapses in nephrotic syndrome. Our study has 
other limitations also as only seven patients were studied, 
no controls were used and no immunologic criteria used 
for identifying and diagnosing allergy. 
CONCLUSION 
The study has given an insight that the patients with 
idiopathic nephrotic syndrome should be evaluated for 
associated atopic disorders. In a child with steroid 
sensitive FRNS and associated recurrent wheezing or 
rhinitis, trial of inhalational steroids after remission may 
decrease or prevent further relapses. 
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